Physician profile
Hamilton Cessac
NPI 1821143389
$1,696.10
in general payments reported to CMS, 2019-2025
9 companies · $225 in 2025
The $225 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $409 · 2022: $395 · 2023: $283 · 2024: $384 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $892.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $351.92 | 2021-2024 | Cabenuva, Dovato |
| Ferring Pharmaceuticals INC. | $289.06 | 2022-2023 | Rebyota |
| Gilead Sciences, INC. | $273.53 | 2023-2024 | |
| Abbvie INC. | $246.83 | 2022-2025 | |
| Cumberland Pharmaceuticals, INC. | $216.30 | 2021-2025 | Vibativ |
| Melinta Therapeutics, LLC | $149.73 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $120.82 | 2021 | |
| Shionogi INC | $31.14 | 2021 | |
| Grt US Holding, INC. | $16.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hamilton Cessac listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.